NEW YORK, NY — As the world enters the mid-point of Breast Cancer Awareness Month, a global movement is preparing to shift the spotlight toward the most severe and often misunderstood form of the disease. On October 13, 2026, more than 325 iconic landmarks across all 50 U.S. states and 20 countries will be bathed in teal, green, and pink. This coordinated display marks the annual #LightUpMBC campaign, an initiative led by METAvivor Research and Support to coincide with National Metastatic Breast Cancer (MBC) Awareness Day.
While the "pink ribbon" culture of October often emphasizes early detection and the celebration of "survivorship," the #LightUpMBC campaign addresses a grimmer reality: metastatic breast cancer, also known as Stage 4, currently has no cure. The campaign aims to transform awareness into tangible action, specifically focusing on the urgent need for research funding to extend the lives of those living with terminal diagnoses.
Main Facts: A Global Beacon for Stage 4 Advocacy
The #LightUpMBC campaign is a visual and digital event designed to honor the lives lost to metastatic breast cancer and to provide a platform for the estimated hundreds of thousands of people currently living with the disease. The 2026 event represents the largest iteration of the campaign to date, spanning 195 cities worldwide.
Metastatic breast cancer occurs when cancer cells break away from the original tumor in the breast and travel through the bloodstream or lymphatic system to form new tumors in distant organs—most commonly the bones, liver, lungs, or brain. Despite advances in early-stage treatment, MBC remains the cause of nearly all breast cancer deaths.
The centerpiece of the evening is #LightUpMBC Live, a virtual broadcast scheduled for 8 p.m. ET / 5 p.m. PT. The program, which is free to the public, will stream across YouTube, Facebook Live, and LiveOne. It serves as a bridge between the physical illuminations of landmarks and the personal stories of patients, featuring scientific updates from leading oncologists and musical performances from Broadway stars.
Crucially, the campaign is a primary fundraiser for METAvivor, the only national organization in the United States dedicated exclusively to funding Stage 4 metastatic breast cancer research. According to the organization, 100% of the net proceeds from the campaign and the livestream are funneled directly into research grants.
Chronology: From a Single Bridge to a Global Phenomenon
The origins of #LightUpMBC are rooted in a personal promise and a local tribute that resonated far beyond its initial scope. The campaign was founded by Laura Inahara in honor of her best friend, Jessica Moore, who was diagnosed with metastatic breast cancer at the age of 32 and passed away just four years later.
- 2017: The movement began with a single landmark—the Memorial Bridge in Portsmouth, New Hampshire. Jessica Moore had expressed a wish to see one local landmark lit in the MBC colors to bring attention to the unique struggles of Stage 4 patients.
- 2018–2020: The initiative gained traction through social media, with patient advocates in other states petitioning their local governments and building managers to join the cause. The campaign officially partnered with METAvivor to ensure that the awareness generated was backed by a mission for scientific progress.
- 2021–2025: Even during the global pandemic, the campaign expanded digitally. The "Live" broadcast was introduced to provide a sense of community for patients who were often immunocompromised and unable to gather in person. By 2025, the number of participating landmarks had surpassed 250.
- 2026: The current year marks a milestone with over 325 landmarks, including some of the most recognizable structures in the world, such as One World Trade Center in New York City, the Willis Tower in Chicago, and Niagara Falls. International participation has surged, with lights appearing from the Mactan-Cebu Airport in the Philippines to the Ness Bridge in Scotland.
Supporting Data: The Stark Reality of MBC in 2026
The necessity of the #LightUpMBC campaign is underscored by sobering statistics provided by the National Cancer Institute’s SEER (Surveillance, Epidemiology, and End Results) program and METAvivor’s internal data.
The Mortality Rate
In 2026, an estimated 42,670 people in the United States are expected to die from breast cancer. This averages out to approximately 117 deaths every single day. Nearly all of these deaths are the result of metastatic disease. Despite the prevalence of "pink" messaging in October, advocates point out that only about 2% to 5% of overall breast cancer research funding is typically directed toward metastatic research.
Diagnosis and Progression
The data reveals two pathways to an MBC diagnosis:
- De Novo Diagnosis: Some patients are diagnosed with Stage 4 cancer from the very beginning, meaning the cancer had already spread by the time it was detected.
- Recurrence: Others develop metastatic disease months, years, or even decades after completing treatment for early-stage (Stage 1, 2, or 3) breast cancer.
The Financial Impact
Since its inception, the #LightUpMBC campaign has raised over $2.7 million for critical research. These funds are vital because MBC patients are in "forever treatment." Unlike early-stage patients who may finish a course of chemotherapy or surgery and move into remission, MBC patients remain on systemic therapies for the rest of their lives. When a specific treatment stops working—because the cancer has evolved to be resistant—they must switch to a new line of therapy. Research is the only mechanism that provides new "lines" of treatment to keep patients alive.
Official Responses: Voices from the Frontlines
The leadership of METAvivor emphasizes that while the lights are a beautiful tribute, the underlying goal is survival.
Dr. Kelly Shanahan, a physician and the Board President of METAvivor, offers a unique perspective as both a medical professional and a patient. "When I was diagnosed with metastatic breast cancer in 2013, I certainly didn’t think I’d still be here 13 years later," Dr. Shanahan stated. "My hope and the hope of so many others lies in research. METAvivor-funded research is increasingly important these days. #LightUpMBC is the biggest contributor to this research and is also a way to bring us together as a community."
Laura Inahara, the founder of the campaign, reflects on the legacy of the woman who inspired it all. "Jessica Moore hoped to illuminate one local landmark," Inahara said. "Today, her legacy helps families around the world shine a light for the people they love, teach patients with MBC how to advocate for themselves, and has now raised over $2.7 million for critical MBC research."
The 2026 broadcast will be hosted by Tami Eagle Bowling, a creator and advocate who has lived with MBC for 11 years, alongside Broadway performer Kara Lindsay. The inclusion of high-profile artists like two-time Tony Award winner Victoria Clark and Tony Award nominee Dorian Harewood signals a growing recognition of MBC within the cultural sphere, moving the conversation beyond the "warrior" tropes often associated with the disease and into a space of clinical reality and artistic expression.
Implications: Changing the Narrative of Breast Cancer
The #LightUpMBC campaign carries significant implications for the future of oncology and patient advocacy. By choosing the colors teal, green, and pink, the movement intentionally distinguishes itself from the traditional pink ribbon. In this tri-color scheme:
- Teal represents healing and spirituality.
- Green signifies the triumph of spring over winter, symbolizing life and renewal.
- Pink acknowledges the cancer’s origin in the breast.
Shifting from Terminal to Chronic
The ultimate mission of METAvivor and the #LightUpMBC campaign is to shift the medical classification of MBC from a "terminal" disease to a "chronic, survivable condition." Much like HIV/AIDS was transformed from a death sentence to a manageable illness through intensive research and funding in the 1990s, MBC advocates believe that with enough targeted research, Stage 4 breast cancer patients can live long, high-quality lives.
Policy and Funding Shifts
The visibility of 325 landmarks serves as a powerful lobbying tool. As landmarks like Philadelphia City Hall and the Mactan-Cebu Airport illuminate, they send a message to policymakers and pharmaceutical entities that the metastatic community is organized and demanding a larger share of research resources.
Community and Mental Health
For the thousands of patients living with the isolation of a terminal diagnosis, the campaign provides a vital psychological boost. The "Live" broadcast allows patients in remote areas or those too ill to travel to see their struggles validated on a global stage.
As October 13 approaches, the public is encouraged to participate by visiting participating landmarks, taking photographs, and sharing them on social media with the hashtags #LightUpMBC and #METAvivor. By doing so, they contribute to a global effort to ensure that the "pink" of October does not overshadow the urgent, life-and-death needs of the metastatic community.
For a full list of participating landmarks and to access the livestream link, visit the official campaign website at www.lightupmbc.org.
About METAvivor:
METAvivor Research and Support Inc. is a 501(c)(3) non-profit organization that exclusively funds Stage 4 metastatic breast cancer research. METAvivor is the only organization of its kind that uses a rigorous scientific peer-review process, involving both researchers and patient advocates, to ensure that 100% of its net donations go toward the most promising MBC research projects.
About #LightUpMBC:
LightUpMBC is a global landmark campaign that seeks to bring awareness to metastatic breast cancer. Every October 13, the campaign coordinates the illumination of landmarks in the MBC awareness colors of teal, green, and pink, culminating in a global livestream event to fund research and honor those affected by the disease.
About the Author
